The FDA has given Life Technologies 510(k) clearance to market its SeCore HLA typing test kits and 3500 Dx Genetic Analyzers. The company said the devices are the first sequencing-based tools to be cleared in the U.S. for HLA typing.
FDA OKs HLA typing systems from Life Technologies
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan